Shrewsbury, MA, United States of America

Nandkumar N Bhongle

This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: Sepracor, Inc., Sunovion Pharmaceuticals Inc., Wyeth. Active years: 2002-2015.

USPTO Granted Patents = 5 

% Patents Active = 60.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2002-2015

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Nandkumar N Bhongle: Innovator in Pharmaceutical Patents

Introduction

Nandkumar N Bhongle is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various affective disorders. With a total of 5 patents to his name, Bhongle's work has the potential to impact many lives.

Latest Patents

His latest patents focus on methods of using derivatives of (−)-venlafaxine. These patents disclose methods of preparing and compositions comprising these derivatives. They also outline methods for treating and preventing a range of diseases and disorders, including depression, bipolar and manic disorders, attention deficit disorder, Parkinson's disease, epilepsy, obesity, and dementia-related disorders.

Career Highlights

Throughout his career, Nandkumar N Bhongle has worked with prominent companies in the pharmaceutical industry, including Sepracor, Inc. and Sunovion Pharmaceuticals Inc. His experience in these organizations has contributed to his expertise in developing innovative treatments.

Collaborations

Bhongle has collaborated with notable professionals in his field, including Thomas P Jerussi and Chrisantha Hugh Senanayake. These collaborations have likely enriched his research and development efforts.

Conclusion

Nandkumar N Bhongle's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through his inventions. His work continues to pave the way for advancements in treating complex disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…